Literature DB >> 10945412

Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host.

B J Rijnders, E Van Wijngaerden, C Verwaest, W E Peetermans.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10945412     DOI： 10.1007/s001340051261

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Use of probiotics in gastrointestinal disorders: what to recommend?

Authors:  Elizabeth C Verna; Susan Lucak
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

Review 2.  Risk and safety of probiotics.

Authors:  Shira Doron; David R Snydman
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

3.  Synthetic analogues of beta-1,2 oligomannosides prevent intestinal colonization by the pathogenic yeast Candida albicans.

Authors:  Françoise Dromer; Reynald Chevalier; Boualem Sendid; Luce Improvisi; Thierry Jouault; Raymond Robert; Jean Maurice Mallet; Daniel Poulain
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 4.  Saccharomyces boulardii in childhood.

Authors:  Yvan Vandenplas; Oscar Brunser; Hania Szajewska
Journal:  Eur J Pediatr       Date:  2008-12-19       Impact factor: 3.183

Review 5.  Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism.

Authors:  Marco Cassone; Pietro Serra; Francesca Mondello; Antonietta Girolamo; Sandro Scafetti; Eleonora Pistella; Mario Venditti
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

6.  Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients.

Authors:  Beata Sulik-Tyszka; Emilian Snarski; Magda Niedźwiedzka; Małgorzata Augustyniak; Thorvald Nilsen Myhre; Anna Kacprzyk; Ewa Swoboda-Kopeć; Marta Roszkowska; Jadwiga Dwilewicz-Trojaczek; Wiesław Wiktor Jędrzejczak; Marta Wróblewska
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.